Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Seth Purcell

Vascular Surgery Spring Hill, FL Medical Doctor

NPI 1144587841 CMS profile 566548

10441 Quality Dr Ste 205, Spring Hill, FL 34609

Open in the dashboard

General payments

$17,106

168 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Seth Purcell of Spring Hill, FL is reported in the CMS Open Payments database as having received $17,106 across 168 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,002 20
2024 General $561 21
2023 General $1,829 26
2022 General $1,041 30
2021 General $5,252 28
2020 General $1,590 17
2019 General $5,830 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Seth Purcell
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Seth Purcell were reported at $1,002. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Seth Purcell Vascular Surgery median Middle half National median
2019 $5,830 $796 $226–$2,363 $163
2020 $1,590 $348 $118–$1,110 $114
2021 $5,252 $471 $158–$1,421 $132
2022 $1,041 $725 $222–$2,183 $149
2023 $1,829 $836 $257–$2,440 $160
2024 $561 $909 $252–$2,619 $164
2025 $1,002 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AngioDynamics, Inc. $5,255 3 payments
  2. Medtronic Vascular, Inc. $4,570 16 payments
  3. W. L. Gore & Associates, Inc. $1,654 20 payments
  4. Boston Scientific Corporation $1,601 50 payments
  5. Penumbra, Inc. $1,066 3 payments
  6. Abbott Laboratories $757 5 payments
  7. Medtronic, Inc. $749 18 payments
  8. Endologix, Inc. $307 6 payments
  9. Cardiovascular Systems Inc. $222 5 payments
  10. Smith+Nephew, Inc. $126 5 payments
  11. Other $800 37 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,510 159 payments
  2. Education $5,490 5 payments
  3. Grant $4,000 1 payment
  4. Travel and Lodging $1,105 3 payments
Products named General payments · program years 2019–2025
  1. Endurant Aortic Stent Grafts $4,359 12 payments
  2. Auryon Laser System 100-120 Vac $4,028 1 payment
  3. Auryon $1,194 1 payment
  4. RUBY Coil $945 2 payments
  5. GORE TAG Thoracic Endoprosthesis $424 5 payments
  6. EXCLUDER AAA Endoprosthesis $412 4 payments
  7. Endurant Aortic Stent Grafts $349 10 payments
  8. Omnilink Elite vascular stent system $346 1 payment
  9. GORE VIABAHN VBX Balloon Expandable Endo $264 2 payments
  10. General - Atherectomy $251 4 payments
  11. Other $4,633 134 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

101

Median for Vascular Surgery: 122

Drug cost

$14,034

Median for Vascular Surgery: $14,135

Branded share of claims

100%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 20 $13,540
Clopidogrel Clopidogrel Bisulfate Brand 81 $494

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 82 billing codes

Paid by Medicare

$372,690

Medicare's payments for the services billed

Medicare patients

167

Average age 75

Services billed

1,756

94 women, 73 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 60%
Ischemic heart disease 57%
Diabetes 49%
Chronic kidney disease 43%
COPD 40%
Atrial fibrillation 36%
Depression 34%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

168 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record